Vincenzo Di Cerbo

Gene Editing | Next-generation Analytics | Viral Vectors bioprocessing & characterisation

[Vincenzo Di Cerbo @vincdicerbo]

Best way to kick off the day at #ISCT2022 ? Have a 5K run at 6.30 am on San Francisco waterfront! 💪🏼🏃🏼‍♂️

[Vincenzo Di Cerbo @vincdicerbo]

Curious to learn what #analytics for #Lentivirus based #CellTherapy @CGTCatapult is developing? Tune in tomorrow for my talk at PepTalk2022! #PTK22

[Vincenzo Di Cerbo @vincdicerbo]

Kick off your day tomorrow by tuning into our Morning Tips webinar, where we will talk about how #geneediting methods are being used in #cellandgenetherapy.

[Cell and Gene Therapy Catapult @CGTCatapult]

There's still time to join tomorrow’s CGTC Morning Tips #webinar addressing ex vivo and in vivo #geneediting methods🧬☕

Speakers: Vincenzo Di Cerbo, Lead Scientist at CGTC joined by Jon Moore, Executive Chair at Pencil Biosciences.

Register for free!👉 https://t.co/HD85o1pP3L

[Vincenzo Di Cerbo @vincdicerbo]

Nice progress on this technology!

[David R. Liu @davidrliu]

Henry Kim and coworkers report the use of in vivo prime editing in the eye to treat a genetic blindness and in the liver to treat a metabolic disease, achieving disease rescue in both cases with no detected off-target prime editing.

[RaffaellaSantoroLab @LabSantoro]

Please RT. We are recruiting postdocs to work on projects to study #3Dgenome organization in and around the #nucleolus. We developed new methods to identify #NADs…and there are now so many exciting questions to elucidate!
Details in https://t.co/qjKONffdBs

[Bristol Myers Squibb @bmsnews]

#MEDIA: FDA approves our second #CARTcelltherapy for a type of #bloodcancer. https://t.co/wfmeIsuqEw

[Vincenzo Di Cerbo @vincdicerbo]

My grandma-in-law made my day: “if my scientist, inherited [that’s right! 😅] grand-son tells me to do the vaccine, I will certainly do it and recommend it to my friends!” - that’s a scientific accomplishment! #COVID19Vaccine

[Vincenzo Di Cerbo @vincdicerbo]

Please RT! We are looking for a molecular biologist with experience in next-gen sequencing. If you want to apply your NGS skills to exciting cell and gene therapy projects, check the job description at https://t.co/EQPvoGyYIK #hiring #NGS

[Vincenzo Di Cerbo @vincdicerbo]

Always great to catch up with the old gang and meet new faces. So many good memories resurface at these meetings 😊 Thanks @robert_ife !

[Robert Schneider @robert_ife]

Schneider lab reunion - January 2020. Real highlight ! Was nice to see almost all former lab members again !

[Vincenzo Di Cerbo @vincdicerbo]

@KellerValsecchi @Feli_Bas @AsifaAkhtar1 @nature Gosh I thought that was about a friendly encounter...😅 hope you ended up in one piece!

[Vincenzo Di Cerbo @vincdicerbo]

@guifengwei @iScience_CP Congrats Guifeng and Tianyi! I’m so glad to see this work published, Guifeng I still remember how long we talked about the PolII data!! 😄😄

[Vincenzo Di Cerbo @vincdicerbo]

Removing all sorts of notifications alerts from social media apps has been the most empowering action of the month!! 💪🏼#SocialMediaDistancing 😁

[Katy Rezvani, M.D., Ph.D @lab_rezvani]

Our manuscript on generation of CRISPR gene edited SARS-Cov2 specific T cells for immunotherapy of COVID19 is prepublished @biorxivpreprint.https://t.co/cv4NtWQeFj Congratulations @rftbsr9, Nadima, Emily and our collaborators. Looking forward to the clinical trial @MDAndersonNews

[Cell and Gene Therapy Catapult @CGTCatapult]

Recommended reading below from Prof Shinya Yamanaka reviewing two decades of research aimed at overcoming challenges that limit pluripotent stem cell-based therapies reaching their full therapeutic potential🧬📚 We love the cover art too! 🎨😍 #stemcell #celltherapy #readinglist

[Vincenzo Di Cerbo @vincdicerbo]

This is very sad. He was a brilliant scientist and a fantastic speaker. What a loss!

[Tigem Telethon @Tigem_Telethon]

In memory of Paolo Sassone-Corsi,
We are honoured to have had Paolo as member of our Scientific Advisory Board from 2003 to date.
A remarkable colleague, an outstanding scientist and a great person, friendly, honest and fun.

We will miss him dearly.

[Vincenzo Di Cerbo @vincdicerbo]

LOL! 😂

[Vincenzo Di Cerbo @vincdicerbo]

Wow!

[Siavash Kurdistani @VashKurdistani]

After many long years filled w/ delight and disappointment, often in the same day, our paper on a new function of histones is out @ScienceMagazine! Thx to incredible team @NarsisAttar @OA_Campos Maria Vogelauer @jencheng65 and many collaborators.
https://t.co/c2k62462xz

[Vincenzo Di Cerbo @vincdicerbo]

Sounds definitely comprehensive...

[David R. Liu @davidrliu]

Itching to read a 21-page review article (plus 16-page Supplement) on CRISPR nucleases, base editors, transposases, and prime editors with 454 total references? It's your lucky day. Congrats, Andrew and Luke!
Review article: https://t.co/Y8GdUTwpNp
SI: https://t.co/XFZXad8ZAG

[Vincenzo Di Cerbo @vincdicerbo]

BioMarin's hemophilia gene therapy 'Roc solid' after 4 years https://t.co/8aRPDrKjPx